News & Updates

NA therapy can be withdrawn in noncirrhotic CHB patients

25 Apr 2021

Termination of nucleos(t)ide analogue (NA) therapy is feasible in noncirrhotic patients negative for the hepatitis B e-antigen (HBeAg), a recent study has found. In particular, those with low baseline HB surface antigen (HBsAg) levels see better outcomes after NA withdrawal.

NA therapy can be withdrawn in noncirrhotic CHB patients

25 Apr 2021

Increased meat intake may up risk of several non-cancerous conditions

22 Apr 2021 by

An increasing intake of unprocessed red meat and processed meat may be tied to an elevated risk of multiple medical conditions, according to a recent prospective study from the UK.

Increased meat intake may up risk of several non-cancerous conditions

22 Apr 2021

Uncontrolled diabetes mellitus, old age worsen outcomes in advanced cirrhosis

21 Apr 2021

In patients with advanced cirrhosis, uncontrolled diabetes mellitus appears to increase the risk of infections, a recent study has found. When combined with old age, the conditions also hurt survival outlook.

Uncontrolled diabetes mellitus, old age worsen outcomes in advanced cirrhosis

21 Apr 2021

Diets high in protein, unsaturated fats help suppress liver fat

20 Apr 2021

Replacing total dietary carbohydrates with fats does not affect overall liver fat content, while instead replacing it with proteins seems to reduce liver fat, reports a recent meta-analysis.

Diets high in protein, unsaturated fats help suppress liver fat

20 Apr 2021

Difficult‐to‐treat primary biliary cholangitis responds well to triple therapy

06 Apr 2021

Triple therapy with ursodeoxycholic acid, obeticholic acid, and fibrates leads to normalization of biochemical liver tests and pruritus improvement in patients with difficult‐to‐treat primary biliary cholangitis, as shown in a study.

Difficult‐to‐treat primary biliary cholangitis responds well to triple therapy

06 Apr 2021

NAFLD ups glucose intolerance risk despite normal ALT

02 Apr 2021

Fatty liver disease (FLD) is a risk factor for the onset of impaired fasting glucose (IFG) among nonalcoholic adult, a new study has found.

NAFLD ups glucose intolerance risk despite normal ALT

02 Apr 2021

Original New Drug Application Approvals by US FDA (16 - 31 March 2021)

01 Apr 2021

New drug applications approved by US FDA as of 16-31 March 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 31 March 2021)

01 Apr 2021

Modified BCLC boasts good prognostic capability in HCC patients

31 Mar 2021

Adherence to the modified Barcelona Clinic Liver Cancer (BCLC) treatment guidelines is high in Taiwan, particularly among stage 0 and A hepatocellular carcinoma (HCC) patients, a recent study has found. However, nonadherence was prevalent in the treatment of stage B and C patients.

Modified BCLC boasts good prognostic capability in HCC patients

31 Mar 2021

Sustained virological response lowers extrahepatic complications risk in HCV, especially in women

27 Mar 2021

Sustained virological response (SVR) results in a reduction in the risk of extrahepatic complications in patients with hepatitis C virus (HCV) infection, particularly in women, a study has found.

Sustained virological response lowers extrahepatic complications risk in HCV, especially in women

27 Mar 2021

Tacrolimus eases COVID-19 death risk in liver transplant recipients

27 Mar 2021

Mortality from the novel coronavirus disease (COVID-19) is higher among liver transplant (LT) recipients, particularly those who are older and have comorbidities, a recent study has shown. Conversely, the use of tacrolimus appears protective against COVID-19 deaths.

Tacrolimus eases COVID-19 death risk in liver transplant recipients

27 Mar 2021

News & Updates

Filter by Specialty:

Specialty:

NA therapy can be withdrawn in noncirrhotic CHB patients

NA therapy can be withdrawn in noncirrhotic CHB patients

Increased meat intake may up risk of several non-cancerous conditions

Increased meat intake may up risk of several non-cancerous conditions

Uncontrolled diabetes mellitus, old age worsen outcomes in advanced cirrhosis

Uncontrolled diabetes mellitus, old age worsen outcomes in advanced cirrhosis

Diets high in protein, unsaturated fats help suppress liver fat

Diets high in protein, unsaturated fats help suppress liver fat

Difficult‐to‐treat primary biliary cholangitis responds well to triple therapy

Difficult‐to‐treat primary biliary cholangitis responds well to triple therapy

NAFLD ups glucose intolerance risk despite normal ALT

NAFLD ups glucose intolerance risk despite normal ALT

Original New Drug Application Approvals by US FDA (16 - 31 March 2021)

Original New Drug Application Approvals by US FDA (16 - 31 March 2021)

Modified BCLC boasts good prognostic capability in HCC patients

Modified BCLC boasts good prognostic capability in HCC patients

Sustained virological response lowers extrahepatic complications risk in HCV, especially in women

Sustained virological response lowers extrahepatic complications risk in HCV, especially in women

Tacrolimus eases COVID-19 death risk in liver transplant recipients

Tacrolimus eases COVID-19 death risk in liver transplant recipients